The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $529,670 in first-year total cost, median $86,032.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BCMB-G (50)]3
- Drug Discovery for the Nervous System Study Section[DDNS]1
- Molecular Neuropharmacology and Signaling Study Section[MNPS]1
- Special Emphasis Panel[ZRG1 BCMB-U (50)]1
Most frequent institutions
- RESEARCH TRIANGLE INSTITUTE3
- PURDUE UNIVERSITY1
- UNIVERSITY OF MICHIGAN AT ANN ARBOR1
- UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Discovery of GPR6 agonist probes: a novel therapeutic target for drug abuse1R03DA045900-01A1 | GAY, ELAINE ARRINGTON | RESEARCH TRIANGLE INSTITUTE, NC | $94,063 | DDNS |
| 2019 | Examining Novel Fentalogs: Pharmacological Characteristics and Reversibility1R03DA048129-01 | ANAND, JESSICA PRIYA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $78,000 | MNPS |
| 2018 | Neuropeptide FF Receptor Antagonists for Pain Treatment1R03DA045910-01 | NGUYEN, THUY | RESEARCH TRIANGLE INSTITUTE, NC | $102,969 | ZRG1 |
| 2018 | In Vivo Photoaffinity Labeling using Casper Zebrafish for Target Identification1R03DA045833-01 | SCHIEFER, ISAAC T | UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS, OH | $76,750 | ZRG1 |
| 2018 | Development of G-protein biased delta opioid receptor agonist with analgesic potency1R03DA045897-01 | VAN RIJN, RICHARD M. | PURDUE UNIVERSITY, IN | $74,662 | ZRG1 |
| 2017 | Synthesis of Dihydro-beta-erythroidine and analogs for nicotine dependence1R03DA044383-01 | NAMJOSHI, OJAS A. | RESEARCH TRIANGLE INSTITUTE, NC | $103,226 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.